Literature DB >> 9671648

Expression and characterization of the neuropeptide Y Y5 receptor subtype in the rat brain.

Y Dumont1, A Fournier, R Quirion.   

Abstract

The neuropeptide Y Y5 receptor subtype has generated great interest, especially regarding its possible involvement in feeding behaviors. However, its distribution and sites of expression in the mammalian brain are, in large part, unknown because of the lack of selective tools. We demonstrate in this study that specific [125I][Leu31, Pro34]PYY binding is competed in a biphasic manner by BIBP3226, a Y1 receptor antagonist, demonstrating the existence of sensitive and insensitive sites to BIBP3226. Assays performed by using [125I][Leu31,Pro34]PYY in the presence of 1 microM BIBP3226 to block the Y1 receptor subtype revealed a pharmacological profile highly similar to the cloned Y5 receptor. Moreover, results obtained with GW1229 suggest that the Y4 subtype represents only a very small proportion of the total population of NPY receptors in the rat brain. Quantitative receptor autoradiographic data revealed the discrete distribution of [125I][Leu31,Pro34]PYY/BIBP3226-insensitive Y5 sites in the rat brain, with the external plexiform layer of the olfactory bulb, the lateral septum, the anteroventral thalamic nucleus, the CA3 subfield of the ventral hippocampus, the nucleus tractus solitarius, and the area postrema being most enriched. Rather surprisingly, in the hypothalamus, a key structure modulating food intake, only low densities of Y5 binding sites were detected as well as in most other regions of the rat brain. These data suggest that the Y5 receptor protein is expressed and translated by a small percentage of hypothalamic neurons and that the effect of NPY on feeding behaviors likely is mediated by more than one class of NPY receptors. It also indicates that the Y5 receptor may be involved in other biological actions induced by NPY. Taken together, these data represent the first pharmacological demonstration of the expression and discrete localization of the Y5 receptor protein in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9671648      PMCID: PMC6793038     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

Review 1.  Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.

Authors:  Y Dumont; J C Martel; A Fournier; S St-Pierre; R Quirion
Journal:  Prog Neurobiol       Date:  1992       Impact factor: 11.685

2.  Differential distribution of neuropeptide Y1 and Y2 receptors in the rat brain.

Authors:  Y Dumont; A Fournier; S St-Pierre; T W Schwartz; R Quirion
Journal:  Eur J Pharmacol       Date:  1990-12-04       Impact factor: 4.432

Review 3.  XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors.

Authors:  M C Michel; A Beck-Sickinger; H Cox; H N Doods; H Herzog; D Larhammar; R Quirion; T Schwartz; T Westfall
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

4.  Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226.

Authors:  Y Dumont; J A St-Pierre; R Quirion
Journal:  Neuroreport       Date:  1996-03-22       Impact factor: 1.837

5.  Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain.

Authors:  S A Aicher; M Springston; S B Berger; D J Reis; C Wahlestedt
Journal:  Neurosci Lett       Date:  1991-09-02       Impact factor: 3.046

Review 6.  The therapeutic potential of neuropeptide Y. Analgesic, anxiolytic and antihypertensive.

Authors:  R Munglani; M J Hudspith; S P Hunt
Journal:  Drugs       Date:  1996-09       Impact factor: 9.546

7.  Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype.

Authors:  C Gerald; M W Walker; P J Vaysse; C He; T A Branchek; R L Weinshank
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

8.  Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.

Authors:  P J Larsen; S P Sheikh; C R Jakobsen; T W Schwartz; J D Mikkelsen
Journal:  Eur J Neurosci       Date:  1993-12-01       Impact factor: 3.386

9.  SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist.

Authors:  C Serradeil-Le Gal; G Valette; P E Rouby; A Pellet; F Oury-Donat; G Brossard; L Lespy; E Marty; G Neliat; P de Cointet
Journal:  FEBS Lett       Date:  1995-04-03       Impact factor: 4.124

Review 10.  Neuropeptide Y: a novel neuroendocrine peptide in the control of pituitary hormone secretion, and its relation to luteinizing hormone.

Authors:  S P Kalra; W R Crowley
Journal:  Front Neuroendocrinol       Date:  1992-01       Impact factor: 8.606

View more
  12 in total

1.  Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

Authors:  K A Nichol; A Morey; M H Couzens; J Shine; H Herzog; A M Cunningham
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist.

Authors:  Y Dumont; A Cadieux; H Doods; L H Pheng; R Abounader; E Hamel; D Jacques; D Regoli; R Quirion
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

4.  BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.

Authors:  Yvan Dumont; Pierrette Gaudreau; Manuela Mazzuferi; Daniel Langlois; Jean-Guy Chabot; Alain Fournier; Michele Simonato; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 5.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

6.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

7.  Role of the Y5 neuropeptide Y receptor in limbic seizures.

Authors:  D J Marsh; S C Baraban; G Hollopeter; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

8.  NPY receptor subtype in the rabbit isolated ileum.

Authors:  M Félétou; J P Nicolas; M Rodriguez; P Beauverger; J P Galizzi; J A Boutin; J Duhault
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

9.  Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.

Authors:  Yvan Dumont; Mira Thakur; Annette Beck-Sickinger; Alain Fournier; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

10.  Beta-estradiol increases dentate gyrus inhibition in female rats via augmentation of hilar neuropeptide Y.

Authors:  Jana Velísková; Libor Velísek
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.